OncoDiag
Innovative Solutions for Cancer Diagnostics. OncoDiag is a French biotechnology company based in Normandy at one hour from Paris and Rouen cities. The company is focused on developing of non-invasive diagnostic tests for early detection of cancers. Its lead product the Urodiag (CE-IVD) is a urine-based lab test for the surveillance of bladder cancer. The company`s pipeline also includes the Prostadiag test to predict non-evolutive localized prostate cancer and the Colodiag test for the screening of colorectal cancer. The management is assumed by a highly qualified team, with complementary expertise and supported by a scientific advisory board representative of the health sector.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Monitoring
- Market Focus:
- Internationally (various countries)
About us
Executive management
Claude Hennion, PhD
President and CEO
Dr. Claude Hennion is co-founder of OncoDiag and has more than 30 years of experience in the management of start-up and valorisation of innovation. Claude has a Ph.D. in Physics from Paris VI University.
Jean-Pierre Roperch, PhD
Director of Research & Development
Dr. Jean-Pierre Roperch is co-founder of OncoDiag and has more than 20 years of experience developing 'In Vitro' Diagnostic in oncology. Jean-Pierre has a Ph.D. in Cellular and Molecular Biology from Paris VI University.